Viewing Study NCT05215405


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-02-02 @ 1:13 AM
Study NCT ID: NCT05215405
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2025-02-03
First Post: 2022-01-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access Program of Venetoclax and Navitoclax for Pediatric Patients with Relapsed or Refractory ALL or LL
Sponsor: Kathleen Ludwig
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed Childhood ALL View
None Relapsed Childhood Lymphoblastic Lymphoma View
Keywords: